company had been inflating the cost of the intravenous drugs sold to Kentucky Medicaid, at times as much as 1300%. 2010 hepatitis C infections In 2010, a jury in Las Vegas, Nevada, ordered Baxter and Teva Pharmaceuticals to pay $144 million to patients who had been infected with hepatitis C after doctors wrongly reused dirty medical supplies to administer propofol to patients, although the label for propofol clearly states that it is for single-patient use only and that aseptic procedures should be used at all times. Per a 2009 indemnity agreement between Teva (the manufacturer) and Baxter (acting as a distributor on behalf of Teva), the litigation and related settlements were defended and paid by Teva. 2010 infusion pump recall In 2010, Baxter was ordered by the FDA to recall all of their Colleague infusion pumps from the market due to 87 recalls and deaths associated with the pump. 2008–2010 tax avoidance In December 2011, the non-partisan organization Public Campaign criticized Baxter for spending $10.45 million on lobbying and not paying any taxes during 2008–2010, instead getting $66 million in tax rebates, despite making a profit of $926 million. References External links American companies established in 1931 Companies based in Deerfield, Illinois Health care companies established in 1931 Companies listed on the New York Stock Exchange Life sciences industry Multinational companies headquartered in the United States Manufacturing companies based in Illinois Orphan drug companies 1931 establishments in California